Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingling Shan

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
International Immunopharmacology|January 20, 2026
Identification of Siglec-15 as a novel target for CAR-T cell therapy in acute myeloid leukemiaHaidong Cui, Chenyang Zhao, Ting Li, et al.
Veterinary Microbiology|June 18, 2017
A spike-specific whole-porcine antibody isolated from a porcine B cell that neutralizes both genogroup 1 and 2 PEDV strainsFang Fu, Lin Li, Lingling Shan, et al.
Journal of Biomedical Nanotechnology|December 15, 2021
Polyphenol-Based Paclitaxel Prodrug Self-Assembled Nanoplatform for Tumor Synergistic TherapyGuoqiang Rong, Maomao Xu, Suxin Shi, et al.
Biosensors & Bioelectronics|November 6, 2012
Visual detection of STAT5B gene expression in living cell using the hairpin DNA modified gold nanoparticle beaconJianpeng Xue, Lingling Shan, Haiyan Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 20, 2025
Brain-targeting biomimetic nanozyme enhances neuroprotection in ischemic stroke by remodeling the neurovascular unitYan Song, Luyao Wang, Tingting Peng, et al.
International Journal of Nanomedicine|June 17, 2024
Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic TherapyLingling Shan, Yudie Li, Yifan Ma, et al.
Frontiers in Microbiology|June 24, 2020
The Coronavirus PEDV Evades Type III Interferon Response Through the miR-30c-5p/SOCS1 AxisChanglin Wang, Lingling Shan, Shuxin Qu, et al.
Pharmaceutical Biology|November 5, 2024
Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trialsQun Wang, Hui Xie, Zihong Wang, et al.
Biomaterials|May 11, 2019
Self-assembled green tea polyphenol-based coordination nanomaterials to improve chemotherapy efficacy by inhibition of carbonyl reductase 1Lingling Shan, Guizhen Gao, Weiwei Wang, et al.
ACS Nano|February 17, 2018
Organic Semiconducting Photoacoustic Nanodroplets for Laser-Activatable Ultrasound Imaging and Combinational Cancer TherapyWei Tang, Zhen Yang, Sheng Wang, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
International Immunopharmacology|January 20, 2026
Identification of Siglec-15 as a novel target for CAR-T cell therapy in acute myeloid leukemiaHaidong Cui, Chenyang Zhao, Ting Li, et al.
Veterinary Microbiology|June 18, 2017
A spike-specific whole-porcine antibody isolated from a porcine B cell that neutralizes both genogroup 1 and 2 PEDV strainsFang Fu, Lin Li, Lingling Shan, et al.
Journal of Biomedical Nanotechnology|December 15, 2021
Polyphenol-Based Paclitaxel Prodrug Self-Assembled Nanoplatform for Tumor Synergistic TherapyGuoqiang Rong, Maomao Xu, Suxin Shi, et al.
Biosensors & Bioelectronics|November 6, 2012
Visual detection of STAT5B gene expression in living cell using the hairpin DNA modified gold nanoparticle beaconJianpeng Xue, Lingling Shan, Haiyan Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 20, 2025
Brain-targeting biomimetic nanozyme enhances neuroprotection in ischemic stroke by remodeling the neurovascular unitYan Song, Luyao Wang, Tingting Peng, et al.
International Journal of Nanomedicine|June 17, 2024
Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic TherapyLingling Shan, Yudie Li, Yifan Ma, et al.
Frontiers in Microbiology|June 24, 2020
The Coronavirus PEDV Evades Type III Interferon Response Through the miR-30c-5p/SOCS1 AxisChanglin Wang, Lingling Shan, Shuxin Qu, et al.
Pharmaceutical Biology|November 5, 2024
Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trialsQun Wang, Hui Xie, Zihong Wang, et al.
Biomaterials|May 11, 2019
Self-assembled green tea polyphenol-based coordination nanomaterials to improve chemotherapy efficacy by inhibition of carbonyl reductase 1Lingling Shan, Guizhen Gao, Weiwei Wang, et al.
ACS Nano|February 17, 2018
Organic Semiconducting Photoacoustic Nanodroplets for Laser-Activatable Ultrasound Imaging and Combinational Cancer TherapyWei Tang, Zhen Yang, Sheng Wang, et al.
Pageof 5